1. Home
  2. DGICB vs TRDA Comparison

DGICB vs TRDA Comparison

Compare DGICB & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DGICB
  • TRDA
  • Stock Information
  • Founded
  • DGICB 1986
  • TRDA 2016
  • Country
  • DGICB United States
  • TRDA United States
  • Employees
  • DGICB N/A
  • TRDA N/A
  • Industry
  • DGICB Property-Casualty Insurers
  • TRDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • DGICB Finance
  • TRDA Health Care
  • Exchange
  • DGICB Nasdaq
  • TRDA Nasdaq
  • Market Cap
  • DGICB 588.8M
  • TRDA 502.9M
  • IPO Year
  • DGICB N/A
  • TRDA 2021
  • Fundamental
  • Price
  • DGICB $15.86
  • TRDA $10.48
  • Analyst Decision
  • DGICB
  • TRDA Strong Buy
  • Analyst Count
  • DGICB 0
  • TRDA 3
  • Target Price
  • DGICB N/A
  • TRDA $25.67
  • AVG Volume (30 Days)
  • DGICB 1.8K
  • TRDA 122.8K
  • Earning Date
  • DGICB 04-24-2025
  • TRDA 05-06-2025
  • Dividend Yield
  • DGICB 3.56%
  • TRDA N/A
  • EPS Growth
  • DGICB 1026.10
  • TRDA N/A
  • EPS
  • DGICB 1.50
  • TRDA 1.68
  • Revenue
  • DGICB $989,605,050.00
  • TRDA $210,782,000.00
  • Revenue This Year
  • DGICB N/A
  • TRDA N/A
  • Revenue Next Year
  • DGICB $4.06
  • TRDA N/A
  • P/E Ratio
  • DGICB $12.61
  • TRDA $6.21
  • Revenue Growth
  • DGICB 6.71
  • TRDA 63.38
  • 52 Week Low
  • DGICB $10.75
  • TRDA $10.08
  • 52 Week High
  • DGICB $18.50
  • TRDA $21.79
  • Technical
  • Relative Strength Index (RSI)
  • DGICB 68.19
  • TRDA 39.05
  • Support Level
  • DGICB $14.36
  • TRDA $10.15
  • Resistance Level
  • DGICB $15.47
  • TRDA $11.04
  • Average True Range (ATR)
  • DGICB 0.67
  • TRDA 0.52
  • MACD
  • DGICB 0.18
  • TRDA 0.09
  • Stochastic Oscillator
  • DGICB 100.00
  • TRDA 40.50

About DGICB Donegal Group Inc. Class B

Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.

Share on Social Networks: